Inflammatory Bowel Disease

Biotech News

Odyssey Therapeutics IPO Aims to Address IBD “Therapeutic Ceiling”
Biotech News

Evommune $150M IPO to Further Innovation for Chronic Inflammatory Diseases
Clinical Trial News

Obefazimod Shows Remission Improvements in New Phase III Ulcerative Colitis Results
Clinical Trial News

Obefazimod Phase III Success Pushes Abivax Stock to Record Highs
Biotech News

Lilly to Acquire Morphic Therapeutic in $3.2B Deal Boosting IBD Portfolio

Why Use Humanized Mouse Models for Translational Studies in Inflammatory Disorders?

January 24, 2023

Sources of Variability in Inflammatory Bowel Disease Endoscopic Video Interpretation

September 20, 2021

Optimizing Patient Recruitment in Inflammatory Bowel Disease Studies

May 12, 2021

MRI in Crohn’s Disease: Site Set-up and MREn Scoring Systems

May 12, 2021
Life Science News

Inflammatory Bowel Disease Drug Linked to Skin Cancer, But Do the Benefits Outweigh the Risks?
Life Science News

Editing Gut Microbiota Could Be Effective Treatment for Inflammatory Bowel Disease

Pre-Clinical Inflammatory Bowel Disease (IBD) Models

November 13, 2015
Life Science News

Nanoparticles Could Be Used To Treat Inflammatory Bowel Disease
Life Science News

Evolution Of Gut Bacteria Affected By Host Immune System
Life Science News

Ultrasound Drug Delivery For Inflammatory Bowel Disease